Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Matthias May, Anja Rabien et al.|British Journal of Urology|2024Cited by 16
Validation of FGFR screening by uromonitor and therascreen in FFPE tissue in bladder cancer in the context of the clinical-pathological real-world registry study “Bladder BRIDGister”Thorsten Ecke, Ralph M. Wirtz, Elke Veltrup et al.|European Urology|2024Cited by 0